search
Back to results

Scalp Infiltration With Methylprednisolone Plus Ropivacaine for Post-Craniotomy Pain in Children

Primary Purpose

Pain, Postoperative, Post-Craniotomy Headache

Status
Not yet recruiting
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Methylprednisolone
Ropivacaine
Sponsored by
Beijing Tiantan Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pain, Postoperative focused on measuring Postoperative Pain, Post-Craniotomy Headache, Methylprednisolone, Ropivacaine, Pre-emptive Scalp Infiltration, Child

Eligibility Criteria

8 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. An elective craniotomy under general anesthesia;
  2. American Society of Anesthesiologists (ASA) physical status of I or II;
  3. Participates with an anticipated fully recovery within 2 hours postoperatively;
  4. Informed consent by parent(s) and/or legal guardian.

Exclusion Criteria:

  1. History of allergies to any of the study drugs;
  2. Excessive alcohol or drug abuse, chronic opioids use (more than 2 weeks or 3 days per week for more than 1 month), or drugs with confirmed or suspected sedative or analgesic effects; receiving any painkiller within 24 h before surgery; children who received steroids;
  3. Psychiatric disorders;
  4. Uncontrolled epilepsy;
  5. Chronic headache;
  6. Peri-incisional infection;
  7. Body mass index exceeded the 99th percentile for age;
  8. Children who cannot use patient-controlled intravenous analgesia(PCIA) device;
  9. Children who cannot understand an instruction of pain scales before surgery.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    MP plus RP group

    RP group

    Arm Description

    Patients in RP/MP group will receive a peri-incisional scalp infiltration with 0.125% methylprednisolone and 0.2% ropivacaine and normal saline miscible liquids. The assigned solution will be injected subcutaneously by surgeons along the incision and throughout the entire thickness of the scalp before skin incision. The volume of local infiltration solution will be decided by surgeons according to the cut length, and the capacity of the solution will be recorded by investigators.

    Patients in RP group will receive peri-incisional scalp infiltration with 0.2% ropivacaine alone. The assigned solution will be injected subcutaneously by surgeons along the incision and throughout the entire thickness of the scalp before skin incision. The volume of local infiltration solution will be decided by surgeons according to the cut length, and the capacity of the solution will be recorded by investigators.

    Outcomes

    Primary Outcome Measures

    Cumulative fentanyl consumption within 24 hours postoperatively
    The PCIA device provides bolus (0.5µg/kg, 10min lock-out time) and the maximum dose will be limited as 2µg/kg per hour. If the patients feel inadequate analgesia after 5 times of fentanyl bolus, the bolus dose will be increased to 1 µg/kg and the maximum dose will be increased to 4 µg/kg per hour

    Secondary Outcome Measures

    The number of participants who have no fentanyl consumption
    The number of participants who have not pushed the button of patient-controlled intravenous analgesia pump. Both of the initial dose and background infusion of the patient-controlled intravenous analgesia pump in this study will be set at 0. Participants will be advised to push the analgesic demand button if they feel pain.
    The first time to press the patient-controlled intravenous analgesia button
    The first time that the participants press the patient-controlled intravenous analgesia button.
    The total times that participants press patient-controlled intravenous analgesia button
    The total times that participants press patient-controlled intravenous analgesia button including effective presses and ineffective presses.
    Numeric Rating Scale (NRS)
    The NRS is a segmented numeric scale in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of their pain. (0 indicates no pain, 10 indicates the most severe pain imaginable. Significant or moderate pain will be defined as NRS ≥4. Severe pain will be defined as a pain score ≥7.
    Pain control satisfaction score(PCSS)
    PCSS (0 for unsatisfactory, and 10 for very satisfied) will be assessed patient satisfaction
    length of stay (LOS)
    LOS will be recorded as the number of nights spent in hospital after surgery.
    The occurrence of postoperative nausea and vomiting
    Postoperative nausea and vomiting (PONV) was rated by participants as: 0, absent; 1, nausea not requiring treatment; 2, nausea requiring treatment; and 3, vomiting.
    Ramsay Sedation Scale(RSS)
    1: Anxious, agitated, restless; Ramsey 2: Cooperative, oriented, tranquil; Ramsey 3: Responsive to commands only If Asleep; Ramsey 4: Brisk response to light glabellar tap or loud auditory stimulus; Ramsey 5: Sluggish response to light glabellar tap or loud auditory stimulus; Ramsey 6: No response to light glabellar tap or loud auditory stimulus.Oversedation will be defined as a score of >2
    The time to first water and oral intake request, scales of oral intake after operation
    The occurrence of respiratory depression
    Respiratory depression is defined as persistent (more than 1 minutes) oxygen desaturation 90 percent or respiratory rate less than 8 breaths per minute, or oxygen desaturation less than 94 percent along with respiratory rate less than 10 breaths per minute requiring supplemental oxygen to maintain oxygen saturation more than 94 percent in the absence of clinically obvious upper airway obstruction.
    Emergence delirium
    Emergence delirium will be assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale. (1) The child makes eye contact with the caregiver, (2) the child's actions are purposeful, (3) the child is aware of his/her surroundings, (4) the child is restless, and (5) the child is inconsolable. Items 1, 2, and 3 are reversed scored as follows: 4 not at all, 3 just a little, 2 quite a bit, 1 very much, 0 extremely. Items 4 and 5 are scored as follows: 0 not at all, 1 just a little, 2 quite a bit, 3 very much, 4 extremely. The scores of each item were summed to obtain a total PAED scale scores. Emergence agitation will be considered a total score of >12 at any time.
    Heart rate
    Mean arterial pressure
    The total consumption of opioids during the operation
    The total consumption of anaesthetic during the operation
    Incisional related adverse events
    Incisional related adverse events Including delayed incisional healing, incisional infection, intracranial infection, scar healing.
    The occurrence of the Adverse events (AEs) and serious adverse events (SAEs)
    An AE was defined as any untoward medical occurrence. An SAE included death, immediately life-threatening conditions, coma, in-patient hospitalisation or prolongation of existing hospitalisation.

    Full Information

    First Posted
    August 2, 2018
    Last Updated
    October 26, 2021
    Sponsor
    Beijing Tiantan Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03636165
    Brief Title
    Scalp Infiltration With Methylprednisolone Plus Ropivacaine for Post-Craniotomy Pain in Children
    Official Title
    Pre-emptive Scalp Infiltration With Ropivacaine Plus Methylprednisolone vs Ropivacaine Alone for Relief of Postoperative Pain After Craniotomy in Children (RP/MP vs RP)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2021
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    September 1, 2022 (Anticipated)
    Primary Completion Date
    December 2023 (Anticipated)
    Study Completion Date
    December 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Beijing Tiantan Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    At present, pediatric postoperative analgesia has not been fully understood and controlled, particularly craniotomy surgery. On the one hand, professional evaluation of postoperative pain for young children is difficult; on the other hand, the particularity of craniotomy adds (such as consciousness obstacle, sleepiness, et al) disturbance to the pain assessment in children. Although opioids administration is regarded as the first-line analgesic for post-craniotomy pain management, it may be associated with delayed awakening, respiratory depression, hypercarbia and it may interfere with the neurologic examination. For the avoidance of side-effects of systemic opioids, local anesthetics administered around the incision have been performed clinically. However, some studies revealed that the analgesic effect of local anesthetics was unsatisfactory due to its short pain relief duration, steroid as adjuvant can enhance postoperative analgesia and prolong postoperative analgesia time. As is reported that postoperative pain of craniotomy is mainly caused by skin incision and reflection of muscles, preventing the liberation of inflammatory mediators around the incision seems to be more effective than simply blocking nerve conduction. Thus, investigators suppose that pre-emptive scalp infiltration with steroid (Methylprednisolone) plus local anesthetic (ropivacaine) could relieve postoperative pain after craniotomy in children.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pain, Postoperative, Post-Craniotomy Headache
    Keywords
    Postoperative Pain, Post-Craniotomy Headache, Methylprednisolone, Ropivacaine, Pre-emptive Scalp Infiltration, Child

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    90 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    MP plus RP group
    Arm Type
    Experimental
    Arm Description
    Patients in RP/MP group will receive a peri-incisional scalp infiltration with 0.125% methylprednisolone and 0.2% ropivacaine and normal saline miscible liquids. The assigned solution will be injected subcutaneously by surgeons along the incision and throughout the entire thickness of the scalp before skin incision. The volume of local infiltration solution will be decided by surgeons according to the cut length, and the capacity of the solution will be recorded by investigators.
    Arm Title
    RP group
    Arm Type
    Active Comparator
    Arm Description
    Patients in RP group will receive peri-incisional scalp infiltration with 0.2% ropivacaine alone. The assigned solution will be injected subcutaneously by surgeons along the incision and throughout the entire thickness of the scalp before skin incision. The volume of local infiltration solution will be decided by surgeons according to the cut length, and the capacity of the solution will be recorded by investigators.
    Intervention Type
    Drug
    Intervention Name(s)
    Methylprednisolone
    Intervention Description
    The local infiltration solution containing 1.25mg Methylprednisolone per milliliter.
    Intervention Type
    Drug
    Intervention Name(s)
    Ropivacaine
    Intervention Description
    The local infiltration solution containing 2mg Ropivacaine per milliliter.
    Primary Outcome Measure Information:
    Title
    Cumulative fentanyl consumption within 24 hours postoperatively
    Description
    The PCIA device provides bolus (0.5µg/kg, 10min lock-out time) and the maximum dose will be limited as 2µg/kg per hour. If the patients feel inadequate analgesia after 5 times of fentanyl bolus, the bolus dose will be increased to 1 µg/kg and the maximum dose will be increased to 4 µg/kg per hour
    Time Frame
    Within 24 hours after the operation
    Secondary Outcome Measure Information:
    Title
    The number of participants who have no fentanyl consumption
    Description
    The number of participants who have not pushed the button of patient-controlled intravenous analgesia pump. Both of the initial dose and background infusion of the patient-controlled intravenous analgesia pump in this study will be set at 0. Participants will be advised to push the analgesic demand button if they feel pain.
    Time Frame
    Within 24 hours after the operation
    Title
    The first time to press the patient-controlled intravenous analgesia button
    Description
    The first time that the participants press the patient-controlled intravenous analgesia button.
    Time Frame
    Within 24 hours after the operation
    Title
    The total times that participants press patient-controlled intravenous analgesia button
    Description
    The total times that participants press patient-controlled intravenous analgesia button including effective presses and ineffective presses.
    Time Frame
    Within 24 hours after the operation
    Title
    Numeric Rating Scale (NRS)
    Description
    The NRS is a segmented numeric scale in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of their pain. (0 indicates no pain, 10 indicates the most severe pain imaginable. Significant or moderate pain will be defined as NRS ≥4. Severe pain will be defined as a pain score ≥7.
    Time Frame
    At 2 hours, 4 hours, 8 hours, 24 hours,48 hours, 72 hours, 1 week, 2 weeks, 1 month, 3 months, 6 months after surgery
    Title
    Pain control satisfaction score(PCSS)
    Description
    PCSS (0 for unsatisfactory, and 10 for very satisfied) will be assessed patient satisfaction
    Time Frame
    At 24 hours,48 hours, 72 hours, 1 week, 2 weeks, 1 month, 3 months, 6 months after surgery
    Title
    length of stay (LOS)
    Description
    LOS will be recorded as the number of nights spent in hospital after surgery.
    Time Frame
    At 24 hours,48 hours, 72 hours, 1 week, 2 weeks, 1 month, 3 months, 6 months after surgery
    Title
    The occurrence of postoperative nausea and vomiting
    Description
    Postoperative nausea and vomiting (PONV) was rated by participants as: 0, absent; 1, nausea not requiring treatment; 2, nausea requiring treatment; and 3, vomiting.
    Time Frame
    The duration of hospitalization after the operation
    Title
    Ramsay Sedation Scale(RSS)
    Description
    1: Anxious, agitated, restless; Ramsey 2: Cooperative, oriented, tranquil; Ramsey 3: Responsive to commands only If Asleep; Ramsey 4: Brisk response to light glabellar tap or loud auditory stimulus; Ramsey 5: Sluggish response to light glabellar tap or loud auditory stimulus; Ramsey 6: No response to light glabellar tap or loud auditory stimulus.Oversedation will be defined as a score of >2
    Time Frame
    At 2 hours, 4 hours, 8 hours, 24 hours after surgery
    Title
    The time to first water and oral intake request, scales of oral intake after operation
    Time Frame
    Within 24 hours after the operation
    Title
    The occurrence of respiratory depression
    Description
    Respiratory depression is defined as persistent (more than 1 minutes) oxygen desaturation 90 percent or respiratory rate less than 8 breaths per minute, or oxygen desaturation less than 94 percent along with respiratory rate less than 10 breaths per minute requiring supplemental oxygen to maintain oxygen saturation more than 94 percent in the absence of clinically obvious upper airway obstruction.
    Time Frame
    Within 24 hours after the operation
    Title
    Emergence delirium
    Description
    Emergence delirium will be assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale. (1) The child makes eye contact with the caregiver, (2) the child's actions are purposeful, (3) the child is aware of his/her surroundings, (4) the child is restless, and (5) the child is inconsolable. Items 1, 2, and 3 are reversed scored as follows: 4 not at all, 3 just a little, 2 quite a bit, 1 very much, 0 extremely. Items 4 and 5 are scored as follows: 0 not at all, 1 just a little, 2 quite a bit, 3 very much, 4 extremely. The scores of each item were summed to obtain a total PAED scale scores. Emergence agitation will be considered a total score of >12 at any time.
    Time Frame
    Within 24 hours after the operation
    Title
    Heart rate
    Time Frame
    During the operation and at 2 hours, 4 hours, 8 hours, 24 hours after surgery
    Title
    Mean arterial pressure
    Time Frame
    During the operation and at 2 hours, 4 hours, 8 hours, 24 hours after surgery
    Title
    The total consumption of opioids during the operation
    Time Frame
    During procedure
    Title
    The total consumption of anaesthetic during the operation
    Time Frame
    During procedure
    Title
    Incisional related adverse events
    Description
    Incisional related adverse events Including delayed incisional healing, incisional infection, intracranial infection, scar healing.
    Time Frame
    Within 1 month after surgery
    Title
    The occurrence of the Adverse events (AEs) and serious adverse events (SAEs)
    Description
    An AE was defined as any untoward medical occurrence. An SAE included death, immediately life-threatening conditions, coma, in-patient hospitalisation or prolongation of existing hospitalisation.
    Time Frame
    Within 6 month after surgery

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    8 Years
    Maximum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: An elective craniotomy under general anesthesia; American Society of Anesthesiologists (ASA) physical status of I or II; Participates with an anticipated fully recovery within 2 hours postoperatively; Informed consent by parent(s) and/or legal guardian. Exclusion Criteria: History of allergies to any of the study drugs; Excessive alcohol or drug abuse, chronic opioids use (more than 2 weeks or 3 days per week for more than 1 month), or drugs with confirmed or suspected sedative or analgesic effects; receiving any painkiller within 24 h before surgery; children who received steroids; Psychiatric disorders; Uncontrolled epilepsy; Chronic headache; Peri-incisional infection; Body mass index exceeded the 99th percentile for age; Children who cannot use patient-controlled intravenous analgesia(PCIA) device; Children who cannot understand an instruction of pain scales before surgery.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Fang Luo, MD
    Phone
    +86 13611326978
    Email
    13611326978@163.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Hao Ren, MD
    Phone
    +86 18710229893
    Email
    renh2014@126.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Fang Luo
    Organizational Affiliation
    Beijing Tiantan Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided
    Citations:
    PubMed Identifier
    31230016
    Citation
    Zhao C, Jia Y, Jia Z, Xiao X, Luo F. Pre-emptive scalp infiltration with ropivacaine plus methylprednisolone versus ropivacaine alone for relief of postoperative pain after craniotomy in children (RP/MP vs RP): a study protocol for a randomised controlled trial. BMJ Open. 2019 Jun 22;9(6):e027864. doi: 10.1136/bmjopen-2018-027864.
    Results Reference
    derived

    Learn more about this trial

    Scalp Infiltration With Methylprednisolone Plus Ropivacaine for Post-Craniotomy Pain in Children

    We'll reach out to this number within 24 hrs